|
Fusion gene ID: 39346 |
FusionGeneSummary for TRAF4_FASN |
Fusion gene summary |
Fusion gene information | Fusion gene name: TRAF4_FASN | Fusion gene ID: 39346 | Hgene | Tgene | Gene symbol | TRAF4 | FASN | Gene ID | 9618 | 2194 |
Gene name | TNF receptor associated factor 4 | fatty acid synthase | |
Synonyms | CART1|MLN62|RNF83 | FAS|OA-519|SDR27X1 | |
Cytomap | 17q11.2 | 17q25.3 | |
Type of gene | protein-coding | protein-coding | |
Description | TNF receptor-associated factor 4MLN 62RING finger protein 83TRAF4 variant 6cysteine-rich domain associated with RING and Traf domains protein 1cysteine-rich domain associated with ring and TRAF domainmalignant 62metastatic lymph node gene 62 protei | fatty acid synthaseshort chain dehydrogenase/reductase family 27X, member 1 | |
Modification date | 20180522 | 20180522 | |
UniProtAcc | Q9BUZ4 | P49327 | |
Ensembl transtripts involved in fusion gene | ENST00000262395, ENST00000444415, ENST00000262396, | ENST00000306749, ENST00000579758, | |
Fusion gene scores | * DoF score | 2 X 2 X 2=8 | 7 X 7 X 5=245 |
# samples | 2 | 8 | |
** MAII score | log2(2/8*10)=1.32192809488736 | log2(8/245*10)=-1.61470984411521 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: TRAF4 [Title/Abstract] AND FASN [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | TRAF4 | GO:0045860 | positive regulation of protein kinase activity | 16157600 |
Hgene | TRAF4 | GO:0046330 | positive regulation of JNK cascade | 16157600 |
Hgene | TRAF4 | GO:0090073 | positive regulation of protein homodimerization activity | 16157600 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | LGG | TCGA-QH-A6CV-01A | TRAF4 | chr17 | 27071273 | + | FASN | chr17 | 80038798 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000262395 | ENST00000306749 | TRAF4 | chr17 | 27071273 | + | FASN | chr17 | 80038798 | - |
5CDS-intron | ENST00000262395 | ENST00000579758 | TRAF4 | chr17 | 27071273 | + | FASN | chr17 | 80038798 | - |
Frame-shift | ENST00000444415 | ENST00000306749 | TRAF4 | chr17 | 27071273 | + | FASN | chr17 | 80038798 | - |
5CDS-intron | ENST00000444415 | ENST00000579758 | TRAF4 | chr17 | 27071273 | + | FASN | chr17 | 80038798 | - |
Frame-shift | ENST00000262396 | ENST00000306749 | TRAF4 | chr17 | 27071273 | + | FASN | chr17 | 80038798 | - |
5CDS-intron | ENST00000262396 | ENST00000579758 | TRAF4 | chr17 | 27071273 | + | FASN | chr17 | 80038798 | - |
Top |
FusionProtFeatures for TRAF4_FASN |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
TRAF4 | FASN |
Adapter protein and signal transducer that links membersof the tumor necrosis factor receptor (TNFR) family to differentsignaling pathways. Plays a role in the activation of NF-kappa-Band JNK, and in the regulation of cell survival and apoptosis.Regulates activation of NF-kappa-B in response to signalingthrough Toll-like receptors. Required for normal skeletondevelopment, and for normal development of the respiratory tract(By similarity). Required for activation of RPS6KB1 in response toTNF signaling. Modulates TRAF6 functions. {ECO:0000250,ECO:0000269|PubMed:12023963, ECO:0000269|PubMed:12801526,ECO:0000269|PubMed:16052631, ECO:0000269|PubMed:16157600,ECO:0000269|PubMed:18953416, ECO:0000269|PubMed:19937093}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for TRAF4_FASN |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for TRAF4_FASN |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
TRAF4 | RPS6KB1, NCF1, NGFR, LTBR, TRIM37, USP7, SMURF1, CENPE, PRMT5, MYH9, KIF11, PSMC3, CALCOCO2, NPAS2, PDE4DIP, GPRASP1, FTH1, NCF2, TRAF6, TICAM1, IRAK1, MAP3K4, TRAF4, CD40, RIPK2, NOD1, NOD2, TNFRSF9, TNFRSF4, GP1BB, GP6, TGFB1I1, PTK2B, UBE2O, ZNF512B, SMURF2, CHUK, CBL, RNF114, CBLC, DTX3, KDM1A, TGFBR1, TGFBR2, USP15, MAP3K7, ARNT2, TRAF2, BYSL, KRT31, QARS, TP53BP2, TYK2, SUMO1, ZNF3, UBL4A, NOS1AP, MRPL28, WWP1, WWP2, BAHD1, EXOC7, GORASP2, TBC1D7, ISYNA1, ZNF581, WBP11, ALKBH4, SPDL1, BANP, HOMEZ, FBXL18, KRT40, UBL4B, BCL6B, KANSL1, PKD1P1, REXO1L6P, SUZ12, BMI1, RPL14, CATSPER4, HIP1R, FAM90A1, FAM214B, AKT1, CTNNB1, MAGEC2, FAT1, CTAGE5 | FASN | FASN, EWSR1, USP2, HDAC5, PCK1, RAD21, NDRG1, MAPK3, ARRB1, ARRB2, SIRT7, TSG101, ISG15, CUL3, CDK2, DCUN1D1, SHC1, AP2M1, EMD, TP53BP1, EIF4A3, MAGOH, PTPN11, SMURF1, HSP90AB1, HSP90AA1, FN1, VCAM1, NOS2, NPM1, LMNA, PRR12, YWHAQ, FBXO6, CAP1, KIAA1598, SIRT1, TPM3, TPM4, LGR4, PHKG2, ILK, STAU1, HUWE1, FUS, CUL7, OBSL1, CCDC8, EED, PTGR2, KIF3A, IMPDH1, HAUS4, TEAD3, YAP1, ABCC1, AHSA1, ASNS, CARM1, CCT6A, CCT6B, CYP27A1, HSD17B12, PC, PEF1, PIK3C2B, GFPT1, GFPT2, HSPBP1, MTCH1, TARBP1, NTRK1, AKT1, PTEN, HSPA5, KIF11, DNAJC7, IRF3, FOXI1, FOXI2, CRY1, CRY2, FOXL1, MCM2, SNW1, CDC5L, ZNF746, CDH1, USP22, CYLD, COX15, DLD, DLST, DNM1L, HSD17B10, PDHA1, SDHA, VHL, CAD, HIF1A, BRCA1, HDAC6 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for TRAF4_FASN |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | FASN | P49327 | DB01083 | Orlistat | Fatty acid synthase | small molecule | approved|investigational |
Top |
RelatedDiseases for TRAF4_FASN |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | FASN | C0025202 | melanoma | 3 | CTD_human |
Tgene | FASN | C2239176 | Liver carcinoma | 3 | CTD_human |
Tgene | FASN | C1458155 | Mammary Neoplasms | 2 | CTD_human |
Tgene | FASN | C0007193 | Cardiomyopathy, Dilated | 1 | CTD_human |
Tgene | FASN | C0007194 | Hypertrophic Cardiomyopathy | 1 | CTD_human |
Tgene | FASN | C0018801 | Heart failure | 1 | CTD_human |
Tgene | FASN | C0022661 | Kidney Failure, Chronic | 1 | CTD_human |
Tgene | FASN | C0023827 | liposarcoma | 1 | CTD_human |
Tgene | FASN | C0028754 | Obesity | 1 | CTD_human |
Tgene | FASN | C0086132 | Depressive Symptoms | 1 | PSYGENET |
Tgene | FASN | C0919267 | ovarian neoplasm | 1 | CTD_human |
Tgene | FASN | C0948089 | Acute Coronary Syndrome | 1 | CTD_human |
Tgene | FASN | C3714756 | Intellectual Disability | 1 | CTD_human |
Tgene | FASN | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |